|
This presentation page is supported in part by generous support from:

FDA Perspective:
Celia Witten OCTGT Title: Cellular, Tissue and Gene Therapies-Office Update
Novel Therapies:
G. Russell Reiss University of Utah Title : Cell Therapy in the Open Heart
Ann Tsukamoto Stem Cells Inc. Title: Developing Human Neural Stem Cells for Clinical Applications
Scheffer C.G.Tseng Ocular Surface Center Title : Amniotic Membrane Transplantation for Ocular Surface Reconstruction
Joshua Hare Johns Hopkins Medical Institutions Title: Regulatory Issues For Cardiac Cell-Based Therapies Using Mesenchymal Stem Cells
Reporting Events:
Elizabeth J. Read National Institutes of Health Title : Adverse Event & Deviation Reporting for 351 Cell Therapy Products
Elizabeth Ness National Cancer Institute Title : Adverse Event Reporting for IND Clinical Trials
Reporting Scenarios
Release Testing I:
Ellen Areman Biologics Consulting Group Title: Perspectives on Testing Cell Therapy Products
Brenton McCright OCTGT, DCGT Title: Release Testing of Cell Therapy Products
Diane Kadidlo University of Minnesota Title: Evaluating Novel Methods fro Endotoxin Testing of Cellular Products – the PACT Experience
John McMannis MD Anderson Cancer Center Title: Sterility Testing: Alternate Samples
Alla Danilkovitch Osiris Therapeutics, Inc. Title : Developing a Potency Assay for an Adult Mesenchymal Stem Cell Product
Pocheng Liu Dendreon Inc. Title: Potency Assays for an Autologous Active Immunotherapy (Sipuleucel-T)
Release Testing II-Practical Experiences:
Karen Edward Advanced Cell & Gene Therapy, LLC Title: Product Release
Jarett Anderson Mayo Clinic Title : Pancreatic Islet Product Release
Rebecca Haley Aldagen, Inc. Title: Release Criteria for ALDHbr Cells
Facilities Issues for Somatic Cell Therapy Product Manufacture:
James Crim OCBQ, DMPQ Title: Facility Design and CGMP Considerations for Cell Therapy Products
Kevin Sheehan Stanford University Title: Cell Processing Laboratory Construction-Renovating an Existing Lab Space
Linda Kelley University of Utah Title: Designing a ‘New’ GMP Laboratory
Shelly Heimfeld Fred Hutchinson Cancer Research Center Title: Environmental Monitoring in the Cell Processing Laboratory
Douglas Padley Mayo Clinic Title: The Role of Media Fill Evaluations in Process Control for Manufacture of Cellular Therapy Products
INDs 202:
John McMannis MD Anderson Cancer Center Title: INDs 202-Panelists Title: MD Anderson IND Pathway
Steven Hirschfeld OCTGT, DCEPT Title: IND “202” Clinical Perspective
Donald Fink OCTGT, DCGT Title: IND 202 Tutorial: Cellular Therapy INDs- The CMC Section
Elizabeth J. Read National Institutes of Health Title: Recent Experience with Cell Therapy INDs at NIH Clinical Center
D. Michael Strong Puget Sound Blood Center Title: IND 202-The Puget Sound Blood Center Experience
Robert Lindblad EMMES Corporation Title: IND 202-Cell Therapy
Donor Issues:
Zbigniew Szczepiorkowski Dartmouth-Hitchcock Medical Center Title: Donor Issues
Melissa Greenwald OCTGT/DHT Title: Donor Issues Scenario Based Panel “FDA Introduction”
Cord Blood-Future Directions:
Ellen Lazarus OCTGT, DHT Title: FDA Update on Cord Blood Banking Regulations
Joanne Kurtzberg Duke University Title: Cord Blood Scenarios
Elizabeth J. Shpall MD Anderson Cancer Center Title: Ex-Vivo Expanded Cord Blood
James Burdick Health Resources and Services Administration Title: Implementation of the Stem Cell Therapeutic and Research Act of 2005
Professional Certification:
Kathy Loper AABB Title: Professional Certification Overview
Scott Brubaker American Association of Tissue Banks Title: AATB Professional Certification
Patricia A. Tanabe American Society for Clinical Pathology Title: ASCP Certification
Sherry Keramidas Regulatory Affairs Professionals Society Title: Overview of Certification of Regulatory Affairs
Jeanne Linden New York State Department of Health Title: New York State Regulation of Tissue Banks
Kathleen Weiss Biotech Institute of Maryland Title: Training Programs and Impact
Kathy Loper AABB Title: AABB Model: A Certificate Program
The Quest for Compatibility:
Janice Davis-Sproul The Johns Hopkins Medical Institutions Title: The Quest for Compatibility-Session Intro
Jennifer Catalano OCTGT, DCGT Title: The International Conference on Harmonization (ICH) and its Relevance to Cell Therapy
Scott Burger Advanced Cell & Gene Therapy, LLC Title: International Regulations & Standards for Cell Therapy
Angela Ondo The Johns Hopkins Medical Institutions Title : Accreditation Challenges
D. Michael Strong Puget Sound Blood Center Title: Tissue & IND Products
Safa Karandish MD Anderson Cancer Center Title: The Quest for Compatiblity: FACT/Netcord & NMDP
Corporate Sponsored Breakfast Session
PharmaNet: Potency – What’s Appropriate for Cell Therapies?
|